New

Clinical Trial Imaging Market

2021

Clinical Trial Imaging Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Modality (Magnetic Resonance Imaging, Computed Tomography, Ultrasound, Positron Emission Tomography, X-Ray, Echocardiography, Others); Products and Services (Services, Software); End User (Pharmaceutical Companies, Contract Research Organizations, Academic and Government Research Institutes, Biotechnology Companies, Others)

| Report Code: TIPHE100001201 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming

Market Insights

Clinical Trial Imaging Market 2028 By Modality, Products and Services, End User | The Insight Partners

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!

MARKET OVERVIEW



Imaging systems have been utilized in non-clinical and clinical trials to detect diseases since ages. Clinical imaging is now mostly used to obtain undeniable and interpretable human physiology or anatomy information. The clinical inferences drawn from an image are crucial in evaluation of the drug effect. Clinical trial imaging data collection, interpretation, and submission are all improving because to technological advancements. Over the last two decades, the use of imaging in clinical trials has increased significantly. In several trials, imaging data is increasingly being used to support the primary endpoint.

MARKET SCOPE



The "Global Clinical Trial Imaging Market Analysis to 2028" is a specialized and in-depth study of the food and beverages industry with a special focus on the global market trend analysis. The report aims to provide an overview of the clinical trial imaging market with detailed market segmentation by modality, products and services, end user, and geography. The report provides key statistics on the market status of the leading clinical trial imaging market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION



  • Based on modality, the global clinical trial imaging market is segmented into magnetic resonance imaging, computed tomography, ultrasound, positron emission tomography, X-ray, echocardiography, and others.
  • On the basis of products and services, the market is segmented into services and software.
  • Based on end user, the market is bifurcated into pharmaceutical companies, contract research organizations, academic and government research, biotechnology companies, and others.

MARKET DYNAMICS


Drivers



  • Rising Number of Contract Research Organization.
  • Growing in Geriatric Population with Chronic Diseases.
  • Growth in R&D Investments.
  • Growth in the Pharmaceutical and Biotechnological Companies.s

Restraints



  • High Implementation Cost of Imaging Systems.

REGIONAL FRAMEWORK



The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The clinical trial imaging market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the clinical trial imaging market in these regions.

IMPACT OF COVID-19 ON CLINICAL TRIAL IMAGING MARKET


COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities. Because imaging can provide highly relevant data for clinical research, it's no wonder that regulators are seeking it increasingly frequently. Thus, COVID-19 is likely to have positive impact on clinical trial imaging market.

MARKET PLAYERS



The report covers key developments in the clinical trial imaging market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from clinical trial imaging market are anticipated to lucrative growth opportunities in the future with the rising demand for clinical trial imaging in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the clinical trial imaging market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  • Bioclinica
  • Parexel International Corporation.
  • ICON plc
  • IXICO plc
  • Intrinsic Imaging, LLC
  • ERT Clinical
  • BioTelemetry, Inc.
  • Cardiovascular Imaging Technologies
  • Medical Metrics
  • Prism Clinical Imaging

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Clinical Trial Imaging Market - By Modality
1.3.2 Clinical Trial Imaging Market - By Products and Services
1.3.3 Clinical Trial Imaging Market - By End User
1.3.4 Clinical Trial Imaging Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. CLINICAL TRIAL IMAGING MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. CLINICAL TRIAL IMAGING MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. CLINICAL TRIAL IMAGING MARKET - GLOBAL MARKET ANALYSIS
6.1. CLINICAL TRIAL IMAGING - GLOBAL MARKET OVERVIEW
6.2. CLINICAL TRIAL IMAGING - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. CLINICAL TRIAL IMAGING MARKET - REVENUE AND FORECASTS TO 2028 - MODALITY
7.1. OVERVIEW
7.2. MODALITY MARKET FORECASTS AND ANALYSIS
7.3. MAGNETIC RESONANCE IMAGING
7.3.1. Overview
7.3.2. Magnetic Resonance Imaging Market Forecast and Analysis
7.4. COMPUTED TOMOGRAPHY
7.4.1. Overview
7.4.2. Computed Tomography Market Forecast and Analysis
7.5. ULTRASOUND
7.5.1. Overview
7.5.2. Ultrasound Market Forecast and Analysis
7.6. POSITRON EMISSION TOMOGRAPHY
7.6.1. Overview
7.6.2. Positron Emission Tomography Market Forecast and Analysis
7.7. X-RAY
7.7.1. Overview
7.7.2. X-Ray Market Forecast and Analysis
7.8. ECHOCARDIOGRAPHY
7.8.1. Overview
7.8.2. Echocardiography Market Forecast and Analysis
7.9. OTHERS
7.9.1. Overview
7.9.2. Others Market Forecast and Analysis
8. CLINICAL TRIAL IMAGING MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCTS AND SERVICES
8.1. OVERVIEW
8.2. PRODUCTS AND SERVICES MARKET FORECASTS AND ANALYSIS
8.3. SERVICES
8.3.1. Overview
8.3.2. Services Market Forecast and Analysis
8.4. SOFTWARE
8.4.1. Overview
8.4.2. Software Market Forecast and Analysis
9. CLINICAL TRIAL IMAGING MARKET - REVENUE AND FORECASTS TO 2028 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. PHARMACEUTICAL COMPANIES
9.3.1. Overview
9.3.2. Pharmaceutical Companies Market Forecast and Analysis
9.4. CONTRACT RESEARCH ORGANIZATIONS
9.4.1. Overview
9.4.2. Contract Research Organizations Market Forecast and Analysis
9.5. ACADEMIC AND GOVERNMENT RESEARCH INSTITUTES
9.5.1. Overview
9.5.2. Academic and Government Research Institutes Market Forecast and Analysis
9.6. BIOTECHNOLOGY COMPANIES
9.6.1. Overview
9.6.2. Biotechnology Companies Market Forecast and Analysis
9.7. OTHERS
9.7.1. Overview
9.7.2. Others Market Forecast and Analysis
10. CLINICAL TRIAL IMAGING MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Clinical Trial Imaging Market Overview
10.1.2 North America Clinical Trial Imaging Market Forecasts and Analysis
10.1.3 North America Clinical Trial Imaging Market Forecasts and Analysis - By Modality
10.1.4 North America Clinical Trial Imaging Market Forecasts and Analysis - By Products and Services
10.1.5 North America Clinical Trial Imaging Market Forecasts and Analysis - By End User
10.1.6 North America Clinical Trial Imaging Market Forecasts and Analysis - By Countries
10.1.6.1 United States Clinical Trial Imaging Market
10.1.6.1.1 United States Clinical Trial Imaging Market by Modality
10.1.6.1.2 United States Clinical Trial Imaging Market by Products and Services
10.1.6.1.3 United States Clinical Trial Imaging Market by End User
10.1.6.2 Canada Clinical Trial Imaging Market
10.1.6.2.1 Canada Clinical Trial Imaging Market by Modality
10.1.6.2.2 Canada Clinical Trial Imaging Market by Products and Services
10.1.6.2.3 Canada Clinical Trial Imaging Market by End User
10.1.6.3 Mexico Clinical Trial Imaging Market
10.1.6.3.1 Mexico Clinical Trial Imaging Market by Modality
10.1.6.3.2 Mexico Clinical Trial Imaging Market by Products and Services
10.1.6.3.3 Mexico Clinical Trial Imaging Market by End User
10.2. EUROPE
10.2.1 Europe Clinical Trial Imaging Market Overview
10.2.2 Europe Clinical Trial Imaging Market Forecasts and Analysis
10.2.3 Europe Clinical Trial Imaging Market Forecasts and Analysis - By Modality
10.2.4 Europe Clinical Trial Imaging Market Forecasts and Analysis - By Products and Services
10.2.5 Europe Clinical Trial Imaging Market Forecasts and Analysis - By End User
10.2.6 Europe Clinical Trial Imaging Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Clinical Trial Imaging Market
10.2.6.1.1 Germany Clinical Trial Imaging Market by Modality
10.2.6.1.2 Germany Clinical Trial Imaging Market by Products and Services
10.2.6.1.3 Germany Clinical Trial Imaging Market by End User
10.2.6.2 France Clinical Trial Imaging Market
10.2.6.2.1 France Clinical Trial Imaging Market by Modality
10.2.6.2.2 France Clinical Trial Imaging Market by Products and Services
10.2.6.2.3 France Clinical Trial Imaging Market by End User
10.2.6.3 Italy Clinical Trial Imaging Market
10.2.6.3.1 Italy Clinical Trial Imaging Market by Modality
10.2.6.3.2 Italy Clinical Trial Imaging Market by Products and Services
10.2.6.3.3 Italy Clinical Trial Imaging Market by End User
10.2.6.4 Spain Clinical Trial Imaging Market
10.2.6.4.1 Spain Clinical Trial Imaging Market by Modality
10.2.6.4.2 Spain Clinical Trial Imaging Market by Products and Services
10.2.6.4.3 Spain Clinical Trial Imaging Market by End User
10.2.6.5 United Kingdom Clinical Trial Imaging Market
10.2.6.5.1 United Kingdom Clinical Trial Imaging Market by Modality
10.2.6.5.2 United Kingdom Clinical Trial Imaging Market by Products and Services
10.2.6.5.3 United Kingdom Clinical Trial Imaging Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Clinical Trial Imaging Market Overview
10.3.2 Asia-Pacific Clinical Trial Imaging Market Forecasts and Analysis
10.3.3 Asia-Pacific Clinical Trial Imaging Market Forecasts and Analysis - By Modality
10.3.4 Asia-Pacific Clinical Trial Imaging Market Forecasts and Analysis - By Products and Services
10.3.5 Asia-Pacific Clinical Trial Imaging Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Clinical Trial Imaging Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Clinical Trial Imaging Market
10.3.6.1.1 Australia Clinical Trial Imaging Market by Modality
10.3.6.1.2 Australia Clinical Trial Imaging Market by Products and Services
10.3.6.1.3 Australia Clinical Trial Imaging Market by End User
10.3.6.2 China Clinical Trial Imaging Market
10.3.6.2.1 China Clinical Trial Imaging Market by Modality
10.3.6.2.2 China Clinical Trial Imaging Market by Products and Services
10.3.6.2.3 China Clinical Trial Imaging Market by End User
10.3.6.3 India Clinical Trial Imaging Market
10.3.6.3.1 India Clinical Trial Imaging Market by Modality
10.3.6.3.2 India Clinical Trial Imaging Market by Products and Services
10.3.6.3.3 India Clinical Trial Imaging Market by End User
10.3.6.4 Japan Clinical Trial Imaging Market
10.3.6.4.1 Japan Clinical Trial Imaging Market by Modality
10.3.6.4.2 Japan Clinical Trial Imaging Market by Products and Services
10.3.6.4.3 Japan Clinical Trial Imaging Market by End User
10.3.6.5 South Korea Clinical Trial Imaging Market
10.3.6.5.1 South Korea Clinical Trial Imaging Market by Modality
10.3.6.5.2 South Korea Clinical Trial Imaging Market by Products and Services
10.3.6.5.3 South Korea Clinical Trial Imaging Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Clinical Trial Imaging Market Overview
10.4.2 Middle East and Africa Clinical Trial Imaging Market Forecasts and Analysis
10.4.3 Middle East and Africa Clinical Trial Imaging Market Forecasts and Analysis - By Modality
10.4.4 Middle East and Africa Clinical Trial Imaging Market Forecasts and Analysis - By Products and Services
10.4.5 Middle East and Africa Clinical Trial Imaging Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Clinical Trial Imaging Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Clinical Trial Imaging Market
10.4.6.1.1 South Africa Clinical Trial Imaging Market by Modality
10.4.6.1.2 South Africa Clinical Trial Imaging Market by Products and Services
10.4.6.1.3 South Africa Clinical Trial Imaging Market by End User
10.4.6.2 Saudi Arabia Clinical Trial Imaging Market
10.4.6.2.1 Saudi Arabia Clinical Trial Imaging Market by Modality
10.4.6.2.2 Saudi Arabia Clinical Trial Imaging Market by Products and Services
10.4.6.2.3 Saudi Arabia Clinical Trial Imaging Market by End User
10.4.6.3 U.A.E Clinical Trial Imaging Market
10.4.6.3.1 U.A.E Clinical Trial Imaging Market by Modality
10.4.6.3.2 U.A.E Clinical Trial Imaging Market by Products and Services
10.4.6.3.3 U.A.E Clinical Trial Imaging Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Clinical Trial Imaging Market Overview
10.5.2 South and Central America Clinical Trial Imaging Market Forecasts and Analysis
10.5.3 South and Central America Clinical Trial Imaging Market Forecasts and Analysis - By Modality
10.5.4 South and Central America Clinical Trial Imaging Market Forecasts and Analysis - By Products and Services
10.5.5 South and Central America Clinical Trial Imaging Market Forecasts and Analysis - By End User
10.5.6 South and Central America Clinical Trial Imaging Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Clinical Trial Imaging Market
10.5.6.1.1 Brazil Clinical Trial Imaging Market by Modality
10.5.6.1.2 Brazil Clinical Trial Imaging Market by Products and Services
10.5.6.1.3 Brazil Clinical Trial Imaging Market by End User
10.5.6.2 Argentina Clinical Trial Imaging Market
10.5.6.2.1 Argentina Clinical Trial Imaging Market by Modality
10.5.6.2.2 Argentina Clinical Trial Imaging Market by Products and Services
10.5.6.2.3 Argentina Clinical Trial Imaging Market by End User
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL CLINICAL TRIAL IMAGING MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Middle East and Africa
11.5 South and Central America
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. CLINICAL TRIAL IMAGING MARKET, KEY COMPANY PROFILES
13.1. BIOCLINICA
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. PAREXEL INTERNATIONAL CORPORATION.
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. ICON PLC
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. IXICO PLC
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. INTRINSIC IMAGING, LLC
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. ERT CLINICAL
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. BIOTELEMETRY, INC.
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. CARDIOVASCULAR IMAGING TECHNOLOGIES
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. MEDICAL METRICS
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. PRISM CLINICAL IMAGING
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS




The List of Companies

1. Bioclinica
2. Parexel International Corporation.
3. ICON plc
4. IXICO plc
5. Intrinsic Imaging, LLC
6. ERT Clinical
7. BioTelemetry, Inc.
8. Cardiovascular Imaging Technologies
9. Medical Metrics
10. Prism Clinical Imaging
11. Biomedical Systems
12. PAREXEL International Corporation
13. Radiant Sage, LLC
14. WorldCare Clinical, LLC
15. Navitas Life Sciences
16. Resonance Health
17. Lyscaut Medical Imaging Company
18. Quotient Sciences
19. Image Core Lab
20. Perspectum Diagnostics
21. Anagram 4 clinical trials
22. Medpace

TIPHE100001201
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.